Reported 3 days ago
Elon Musk's Neuralink has raised $650 million in a recent funding round as it begins clinical trials for its brain implant device that enables communication between the brain and digital devices. The trials involve patients with severe paralysis using the technology to control devices with their thoughts. The FDA has granted breakthrough status to Neuralink's speech restoration device, accelerating its development. Key investors in this funding round include ARK Invest and Sequoia Capital.
Source: YAHOO